Literature DB >> 22942353

A pathologist's view of airway obstruction in chronic obstructive pulmonary disease.

James C Hogg.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22942353      PMCID： PMC3443802          DOI： 10.1164/rccm.201206-1130ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  21 in total

1.  Panlobular emphysema: anatomy and pathodynamics.

Authors:  J P WYATT; V W FISCHER; H C SWEET
Journal:  Dis Chest       Date:  1962-03

2.  The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis.

Authors:  J G LEOPOLD; J GOUGH
Journal:  Thorax       Date:  1957-09       Impact factor: 9.139

3.  The histology of localized emphysema.

Authors:  K H McLEAN
Journal:  Australas Ann Med       Date:  1957-11

4.  The secondary lobule in the adult human lung, with special reference to its appearance in bronchograms.

Authors:  L REID
Journal:  Thorax       Date:  1958-06       Impact factor: 9.139

5.  Peripheral lung resistance in normal and asthmatic subjects.

Authors:  E M Wagner; M C Liu; G G Weinmann; S Permutt; E R Bleecker
Journal:  Am Rev Respir Dis       Date:  1990-03

6.  The number and dimensions of small airways in emphysematous lungs.

Authors:  K Matsuba; W M Thurlbeck
Journal:  Am J Pathol       Date:  1972-05       Impact factor: 4.307

7.  Direct assessment of small airways reactivity in human subjects.

Authors:  E M Wagner; E R Bleecker; S Permutt; M C Liu
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

8.  Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure.

Authors:  M Yanai; K Sekizawa; T Ohrui; H Sasaki; T Takishima
Journal:  J Appl Physiol (1985)       Date:  1992-03

9.  Partitioning of pulmonary impedance in excised human and canine lungs.

Authors:  H Van Brabandt; M Cauberghs; E Verbeken; P Moerman; J M Lauweryns; K P Van de Woestijne
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-12

10.  Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

Authors:  R Yuan; J C Hogg; P D Paré; D D Sin; J C Wong; Y Nakano; A M McWilliams; S Lam; H O Coxson
Journal:  Thorax       Date:  2009-09-03       Impact factor: 9.139
View more
  7 in total

1.  Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).

Authors:  Xia Wei; Qi Ding; Nan Yu; Jiuyun Mi; Jingting Ren; Jie Li; Shudi Xu; Yanzhong Gao; Youmin Guo
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

2.  Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.

Authors:  Peter J Castaldi; Jennifer Dy; James Ross; Yale Chang; George R Washko; Douglas Curran-Everett; Andre Williams; David A Lynch; Barry J Make; James D Crapo; Russ P Bowler; Elizabeth A Regan; John E Hokanson; Greg L Kinney; Meilan K Han; Xavier Soler; Joseph W Ramsdell; R Graham Barr; Marilyn Foreman; Edwin van Beek; Richard Casaburi; Gerald J Criner; Sharon M Lutz; Steven I Rennard; Stephanie Santorico; Frank C Sciurba; Dawn L DeMeo; Craig P Hersh; Edwin K Silverman; Michael H Cho
Journal:  Thorax       Date:  2014-02-21       Impact factor: 9.139

3.  Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.

Authors:  Moumita Ghosh; York E Miller; Ichiro Nakachi; Jennifer B Kwon; Anna E Barón; Alexandra E Brantley; Daniel T Merrick; Wilbur A Franklin; Robert L Keith; R William Vandivier
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

4.  Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.

Authors:  Diandian Li; Yanqiu Wu; Shujin Guo; Jiangyue Qin; Mei Feng; Yunfei An; Junlong Zhang; Yanping Li; Shuguang Xiong; Hui Zhou; Qianglin Zeng; Lei Chen; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-28

5.  β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease - A Danish Nationwide Study of 1·3 Million Individuals.

Authors:  Anne Orholm Nielsen; Lars Pedersen; Birgitte Fischer Sode; Morten Dahl
Journal:  EClinicalMedicine       Date:  2019-01-29

6.  S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.

Authors:  David C L Lam; Stanley C H Chan; Judith C W Mak; Craig Freeman; Mary S M Ip; Daisy K Y Shum
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

7.  Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients.

Authors:  Bente Frisk; Birgitte Espehaug; Jon A Hardie; Liv I Strand; Rolf Moe-Nilssen; Tomas M L Eagan; Per S Bakke; Einar Thorsen
Journal:  Physiol Rep       Date:  2014-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.